Mandate

Vinge advises Swedish Match in relation to Scandinavian Tobacco Group’s listing on Nasdaq Copenhagen

February 19, 2016

Vinge advised Swedish Match AB in relation to Scandinavian Tobacco Group A/S’s listing on Nasdaq Copenhagen. Scandinavian Tobacco Group (STG) is a world leading manufacturer of cigars and pipe tobacco.

A prospectus was published on 28 January 2016 and the first day of trading on Nasdaq Copenhagen was on 10 February 2016. The price in the offering was set at DKK 100 per share, corresponding to a market capitalisation of DKK 10 billion for STG.

Swedish Match owned, through Swedish Match Cigars Holding AB, 49 percent of STG before the offering and owns 31.2 percent of STG after completion of the offering and prior to any exercise of the overallotment option.

Vinge’s team primarily consisted of Charlotte Levin, Jonas Johansson, Joakim Hagberg, Amanda Knutsson, Malte Hedlund and Maria Schultzberg.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026